Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Baumgarten
High Efficacy of Sofosbuvir/Velpatasvir and Impact of Baseline Resistance-Associated Substitutions in Hepatitis C Genotype 3 Infection
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Predictors of Postpartum Diabetes in Women With Gestational Diabetes Mellitus
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial
Gastroenterology
Hepatology
Gastroenterology
Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia
American Journal of Hematology
Hematology
Prevalence of Resistance Associated Substitutions and Efficacy of Baseline Resistance-Guided Chronic Hepatitis C Treatment in Spain From the GEHEP-004 Cohort
PLoS ONE
Multidisciplinary
NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection
Hepatology
Medicine
Hepatology
Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Gastroenterology
Hepatology
Gastroenterology
Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus
Hepatology
Medicine
Hepatology
Baseline Hepatitis C Virus Resistance-Associated Substitutions Present at Frequencies Lower Than 15% May Be Clinically Significant
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
Efficacy and Safety of Generic Daclatasvir + Sofosbuvir ± Ribavirin in Treatment of Genotype 3 Infected Hepatitis C Patients - A Real Life Experience From Pakistan
Hepatoma Research
